DLD Asset Management’s Tetraphase Pharmaceuticals TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-11,500
Closed -$1.64M – 117
2017
Q2
$1.64M Buy
+11,500
New +$1.78M 0.21% 39

Other funds holding TTPH

DLD Asset Management's TTPH Position: Q3 2017 in Review

DLD Asset Management sold out of Tetraphase Pharmaceuticals (TTPH) in Q3 2017, closing a stake of 11,500 shares — an estimated $1.64M sold.

DLD Asset Management first reported a position in TTPH in Q2 2017 and held it in 1 quarter. The position peaked at $1.64M in Q2 2017. 94 funds tracked by Wall St. Rank hold TTPH as of Q3 2017.

  • DLD Asset Management reported no remaining Tetraphase Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • DLD Asset Management sold 11,500 Tetraphase Pharmaceuticals shares in Q3 2017, an estimated $1.64M.
  • DLD Asset Management first reported a position in Tetraphase Pharmaceuticals in Q2 2017 and held it in 1 quarter.
  • DLD Asset Management's Tetraphase Pharmaceuticals position peaked at $1.64M in Q2 2017.
  • 94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q3 2017.

Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.